New England Journal of Medicine (2016) Lincoff AM, Brown-Frandsen K, et al
Levocarnitine-containing compounds may warrant carnitine level monitoring in people with kidney impairment
Experience the beautiful beaches and active lifestyle of Ormond Beach with renewed confidence and vitality by embarking on your weight loss journey with us
Brown and beige adipose tissue: One or different targets for treatment of obesity and obesity-related metabolic disorders
Before recommending semaglutide, tirzepatide, or another medically supervised weight-loss strategy, a physician may review weight history, prior weight-loss attempts, BMI, waist circumference, body composition goals, A1C, fasting glucose, insulin-resistance risk, cholesterol, triglycerides, blood pressure, liver enzymes, fatty liver risk, kidney function, current medications, diabetes medication use, history of pancreatitis, gallbladder disease, gastrointestinal symptoms, thyroid history, protein intake, exercise habits, sleep quality, hormonal symptoms, inflammation-related concerns, side-effect tolerance, and long-term maintenance planning
TGA Approved Terminology for Medicines (PDF)
